Search Page

1

Cite

Share

Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis.

Okano M, Gross TG. Okano M, et al. Among authors: gross tg. Am J Hematol. 1996 Oct;53(2):111-5. doi: 10.1002/(SICI)1096-8652(199610)53:2<111::AID-AJH8>3.0.CO;2-2. Am J Hematol. 1996. PMID: 8892735 Review.

Cite

Share

2

Cite

Share

Tumor immune surveillance defect of X-linked severe combined immunodeficiency is not Epstein-Barr virus specific.

Mustillo P, Bajwa RP, Termuhlen AM, Nicol K, Scherzer R, Jaffe R, Filipovich AH, Gross TG. Mustillo P, et al. Among authors: gross tg. Pediatr Blood Cancer. 2008 Nov;51(5):706-9. doi: 10.1002/pbc.21651. Pediatr Blood Cancer. 2008. PMID: 18615703

Cite

Share

3

Cite

Share

[X-linked lymphoproliferative syndrome].

Pelkonen T, Lanning M, Kähkönen M, Gross TG. Pelkonen T, et al. Among authors: gross tg. Duodecim. 1996;112(5):407-11. Duodecim. 1996. PMID: 10592602 Finnish. No abstract available.

Cite

Share

4

Cite

Share

Concurrent Epstein-Barr virus associated non-Hodgkin lymphoma and recurrent Hodgkin disease.

Gross TG, Hilden JM, Manivel JC, Ramsay NK, MacMahon EM. Gross TG, et al. J Pediatr Hematol Oncol. 1996 May;18(2):182-6. doi: 10.1097/00043426-199605000-00018. J Pediatr Hematol Oncol. 1996. PMID: 8846135

Cite

Share

5

Cite

Share

Acute or chronic life-threatening diseases associated with Epstein-Barr virus infection.

Okano M, Gross TG. Okano M, et al. Among authors: gross tg. Am J Med Sci. 2012 Jun;343(6):483-9. doi: 10.1097/MAJ.0b013e318236e02d. Am J Med Sci. 2012. PMID: 22104426 Review.

Cite

Share

6

Cite

Share

Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patients.

Okano M, Gross TG. Okano M, et al. Among authors: gross tg. Expert Rev Anti Infect Ther. 2007 Jun;5(3):403-13. doi: 10.1586/14787210.5.3.403. Expert Rev Anti Infect Ther. 2007. PMID: 17547505 Review.

Cite

Share

7

Cite

Share

Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.

Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC. Gross TG, et al. J Clin Oncol. 2005 Sep 20;23(27):6481-8. doi: 10.1200/JCO.2005.08.074. J Clin Oncol. 2005. PMID: 16170157 Clinical Trial.

Cite

Share

8

Cite

Share

Epstein-Barr virus associated disease following blood or marrow transplant.

Gross TG, Loechelt BJ. Gross TG, et al. Pediatr Transplant. 2003;7 Suppl 3:44-50. doi: 10.1034/j.1399-3046.7.s3.6.x. Pediatr Transplant. 2003. PMID: 12603692 Review.

Cite

Share

9

Cite

Share

Differential cellular susceptibility to Epstein-Barr virus infection in a patient with X-linked lymphoproliferative disease.

Okano M, Thiele GM, Gross TG, Davis JR, Purtilo DT. Okano M, et al. Among authors: gross tg. J Med Virol. 1990 Sep;32(1):47-52. doi: 10.1002/jmv.1890320108. J Med Virol. 1990. PMID: 2173737

Cite

Share

10

Cite

Share

Treatment of Epstein-Barr virus-associated posttransplant lymphoproliferative disorders.

Gross TG. Gross TG. J Pediatr Hematol Oncol. 2001 Jan;23(1):7-9. doi: 10.1097/00043426-200101000-00003. J Pediatr Hematol Oncol. 2001. PMID: 11196278 Review. No abstract available.

Cite

Share